{"id":"W2909090268","doi":"10.1111/bjd.17624","title":"Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"LEO Pharma; Sun Pharma; National Institute for Health and Care Research; Celgene; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Adverse effect; Dermatology Life Quality Index; Randomized controlled trial; Plaque psoriasis; Physical therapy; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02579677,0.000967167,0.006220426,0.001588905,0.0007201888,0.003037624,0.002791314,0.004255789,0.003721295],"category_scores_gemma":[0.03490162,0.000602645,0.00572331,0.001760407,0.001180789,0.002154427,0.000877983,0.005170119,0.0008596579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004172722,"about_ca_system_score_gemma":0.005216056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001935455,"about_ca_topic_score_gemma":0.004001355,"domain_scores_codex":[0.9918046,0.004195145,0.001877963,0.0004324898,0.001420853,0.000268933],"domain_scores_gemma":[0.95175,0.03302746,0.00587687,0.0007833082,0.007586608,0.0009757784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03164526,0.0003888728,0.0008635998,0.3101371,0.01455601,0.0002739267,0.000379072,0.0004351968,0.001596422,0.003729531,0.04971291,0.5862821],"study_design_scores_gemma":[0.03622913,0.01383738,0.0070113,0.496079,0.05150647,0.0006716747,0.0006712655,0.0007470084,0.001538486,0.006364363,0.3851828,0.0001611191],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009606708,0.9901073,0.0001040977,0.005433085,0.002457879,0.0002054784,0.00006420093,0.000009857162,0.0006573516],"genre_scores_gemma":[0.03514826,0.924148,0.001725614,0.02591037,0.01109971,0.0007088651,0.0002049072,0.00003143832,0.001022877],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02579677,"threshold_uncertainty_score":0.136428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01195676210780352,"score_gpt":0.267093028271159,"score_spread":0.2551362661633556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}